To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04037254
Title Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer
Acronym NADIR
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors NRG Oncology
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.